QUADRANT CAPITAL GROUP LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 267 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,809
-51.9%
147
-42.1%
0.00%
-50.0%
Q2 2023$18,314
+0.8%
254
+2.8%
0.00%0.0%
Q1 2023$18,170
+94.3%
247
+76.4%
0.00%
+100.0%
Q4 2022$9,352
-28.1%
140
-8.5%
0.00%
-50.0%
Q3 2022$13,000
+1200.0%
153
+856.2%
0.00%
Q2 2022$1,0000.0%16
+33.3%
0.00%
Q1 2022$1,000
-50.0%
120.0%0.00%
Q4 2021$2,000
-33.3%
12
-33.3%
0.00%
Q3 2021$3,000
+50.0%
18
+50.0%
0.00%
Q2 2021$2,0000.0%120.0%0.00%
Q1 2021$2,000
+100.0%
120.0%0.00%
Q4 2020$1,000
-80.0%
12
-75.5%
0.00%
-100.0%
Q2 2020$5,000
-88.1%
49
-91.6%
0.00%
-85.7%
Q1 2020$42,000580
+5700.0%
0.01%
Q4 2019$0
-100.0%
10
-52.4%
0.00%
Q3 2019$1,000
-97.1%
21
-93.3%
0.00%
-100.0%
Q2 2019$34,000
+3300.0%
313
+1390.5%
0.01%
Q1 2019$1,000
-66.7%
21
-30.0%
0.00%
-100.0%
Q4 2018$3,000
-70.0%
30
-30.2%
0.00%
-66.7%
Q3 2018$10,000
+42.9%
430.0%0.00%
+50.0%
Q2 2018$7,000
+75.0%
43
+43.3%
0.00%
+100.0%
Q1 2018$4,000
+33.3%
300.0%0.00%0.0%
Q4 2017$3,0000.0%300.0%0.00%0.0%
Q3 2017$3,00030
+87.5%
0.00%
Q2 2017$0
-100.0%
160.0%0.00%
Q1 2017$1,0000.0%160.0%0.00%
-100.0%
Q4 2016$1,000
-85.7%
16
-81.0%
0.00%
-80.0%
Q3 2016$7,000
-22.2%
840.0%0.01%
-16.7%
Q2 2016$9,000
+12.5%
840.0%0.01%
+20.0%
Q1 2016$8,000840.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders